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RESPONSE TO COMMENT ON USSAR ET AL.
Regulation of Glucose Uptake and Enteroendocrine
Function by the Intestinal Epithelial Insulin
Receptor. Diabetes 2017;66:886–896
C. Ronald Kahn1 and Siegfried Ussar2
Diabetes 2017;66:e6 | DOI: 10.2337/dbi17-0003
We thank Dr. Brubaker for her letter (1) regarding our
recent publication (2). She raised two questions that we
agree are very important: choice of proper controls and use
of both sexes in animal studies. The use of proper controls
for murine, as well as human, studies is essential to ac-
count for environmental, genetic, and epigenetic effects, as
well as off-target effects of transgenes, drugs, and other
manipulations. In fact, we have published on many of the
caveats of tissue-speciﬁc gene inactivation (3), as well as
the impact of genetic background, the microbiome, and the
housing and breeding environment on such studies (4,5).
In the current study (2), we were able to take advan-
tage of inherent controls in our experimental design. Spe-
ciﬁcally, we did not need a “villin-cre only” control because
we used the same villin-cre transgenic mice to induce loss
of the IGF-I receptor in the intestinal epithelium, and the
resultant mice had no phenotype for any of the parameters
assessed (2). This indicates not only that the intestinal IGF-I
receptor is dispensable for the parameters assessed but also
that the villin-cre transgene used in this study itself did not
mimic the phenotypes observed in the intestinal epithelial
insulin receptor knockout (VILIRKO) mice. Given the com-
mitment of all investigators to minimize stress and pain on
experimental animals and to reduce, reﬁne, and replace
animal experiments where possible, including an additional
“villin-cre only” group is unnecessary and would violate this
tenet.
With regard to studying both sexes, although we did
not explicitly state this, we routinely assess potential
phenotypes in both sexes. As there was no evidence of
sexual dimorphism in the phenotype and no hypothesis
regarding effects of sex on outcome, we focused on males,
both for cost and ethical considerations. We assume that
similar considerations drove Dr. Brubaker to do the same
in her recent publications involving mice, rats, piglets,
and humans, all of which used only males. When we have
observed sex differences in other studies, we have fol-
lowed up on these observations with appropriate
experiments, including administration of sex steroids
or gonadectomy to understand the mechanism (6). This
was not indicated in this study because no sexual dimor-
phism was observed.
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